Skip to main content
Log in

Epidemiology of Endocrine-Related Risk Factors for Breast Cancer

  • Published:
Journal of Mammary Gland Biology and Neoplasia Aims and scope Submit manuscript

Abstract

Ovarian and other hormones are major determinants of breast cancer risk. Particularly important is the accumulative exposure of the breast to circulating levels of the ovarian hormones estradiol and progesterone. A number of breast cancer risk factors can be understood in light of how they affect women's hormone profiles. Age is a marker for the onset and cessation of ovarian activity. Racial differences in hormone profiles correlate with breast cancer incidence patterns. Age at menarche not only serves as the chronological indicator of the onset of ovarian activity, but as a predictor of ovulatory frequency during adolescence and hormone levels in young adults, and has a long-lasting influence on risk. Age at menopause, another established breast cancer risk factor, marks the cessation of ovarian activity. Pregnancy history and lactation experience also are hormonal markers of breast cancer risk. Postmenopausal obesity, which is associated with higher levels of estrogen following cessation of ovarian activity, increases breast cancer risk, whereas physical activity, which can limit menstrual function, reduces risk. A relatively recent area of investigation is prenatal exposures like preeclampsia and low birth weight; both may be associated with lower in utero exposure to estrogen and also may predict lower breast cancer risk as an adult. Improved understanding of these exposures and their potential interactions with breast cancer susceptibility genes may, in the future, improve our prospects for breast cancer prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Raymond, and J. E. Young (eds.) (1997). Cancer Incidence in Five Continents, Vol.7, IARCScientific Publications No. 143, International Agency forResearch on Cancer, Lyon, France.

  2. C.C. Boring, T.S. Squires, and T. Tong (1993). Cancer Statistics 1993. CA: Cancer J.Clin. 43: 7–26.

    Google Scholar 

  3. B.E. Henderson and H.S. Feigelson (2000). Hormonal carcino-genesis. Carcinogenesis 21: 427–433.

    PubMed  Google Scholar 

  4. J. Waterhouse, C. Muir, K. Shanmugaratnam, and J.E. Powell(1982). Cancer Incidence in Five Continents, Vol. 4, IARC ScientificPublications No. 42, International Agency for Researchon Cancer, Lyon, France.

  5. D.M. Parkin, C.S. Muir, S.L. Whelan, Y.T. Gao, J. Ferlay,and J. Powell (eds.) (1992). Cancer Incidence in Five Continents, IARCScientific Publications No. 120, International Agency forResearch on Cancer, Lyon, France.

  6. B.A. Miller, L.N. Kolonel, L. Bernstein, J.L. Young Jr, G.M. Swanson, D. West, C.R. Key, J.M. Liff, C.S. Glover, and G.A. Alexander (eds.) (1996). Racial/Ethnic Patterns of Cancerin the United States 1988–1992I, NIH Pub. No. 96–4104, NationalCancer Institute, Bethesda, MD.

  7. L. A.G. Ries, M.P. Eisner, C.L. Kosary, B.F. Hankey,B.A. Miller, L. Clegg, and B.K. Edwards (eds.) (2001). SEERCancer Statistics Review, 1973–1998, National Cancer Institute,Bethesda, MD.

  8. S. Preston-Martin, M.C. Pike, R.K. Ross, P.A. Jones, and B.E. Henderson (1990). Increased cell division as a cause of humancancer. Cancer Res. 50: 7415–7421.

    PubMed  Google Scholar 

  9. I.A. Mustafa and K.I. Bland (1998). Physiologic effects ofsteroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk. Ann.Surg. 228: 638–651.

    PubMed  Google Scholar 

  10. B.E. Henderson, R.K. Ross, H.L. Judd, M.D. Krailo, and M.C. Pike (1985). Do regular ovulatory cycles increase breastcancer risk? Cancer 56: 1206–1208.

    PubMed  Google Scholar 

  11. U. Goebelsmann and D. Mishell (1979). The menstrual cycle. In D. Mishell and V. Davajan (eds.), Reproductive Endocrinology,Infertility and Contraception, FA Davis, Philadelphia, PA, pp. 67–89.

    Google Scholar 

  12. M.C. Pike, D.V. Spicer, L. Dahmoush, and M.F. Press (1993). Estrogens, progestogens, normal breast cell proliferation, andbreast cancer risk. Epidemiol.Rev. 15: 17–35.

    PubMed  Google Scholar 

  13. L. Bernstein and R.K. Ross (1993). Hormones and breast cancer. Epidemiol.Rev. 15: 48–65.

    PubMed  Google Scholar 

  14. T. Key (1999). Serum estradiol and breast cancer risk. Endocrine-Rel.Cancer 6: 175–180.

    Google Scholar 

  15. H.V. Thomas, G.K. Reeves, and T.J. Key (1997). Endogenousestrogen and postmenopausal breast cancer: Aquantitative review. Cancer Causes Control 8: 922–928.

    PubMed  Google Scholar 

  16. S.E. Hankinson, W.C. Willett, J.E. Manson, G.A. Colditz, D.A. Hunter, D. Spiegelman, R.L. Barbieri, and F.E. Speizer(1998). Plasma sex steroid hormone levels and risk of breastcancer in postmenopausal women. J.Natl.Cancer Inst. 90: 1292–1299.

    PubMed  Google Scholar 

  17. T. Zeginiadou, A.H. Kortsaris, S. Koliais, and O. Antonoglou(1998). Sex hormone binding globulin inhibits strongly the up-takeof estradiol by human breast carcinoma cells via a depri-vativemechanism. Cancer Biochem.Biophys. 16: 253–263.

    PubMed  Google Scholar 

  18. J.F. Dorgan, C. Longcope, H.E. Stephenson, R.T. Falk,R. Miller, C. Franz, L. Kahle, W.S. Campbell, J.A. Tantrea, and A. Schatzkin (1996). Relation of prediagnostic serum estrogenand androgen levels to breast cancer risk. Cancer EpidemiolBiomark.Prev. 5: 533–539.

    Google Scholar 

  19. D.C. Anderson (1974). Sex-hormone-binding globulin. Clin.Endocrinol. 3: 69–96.

    Google Scholar 

  20. L.E. Nachtigall, U. Raju, S. Banerjee, L. Wan, and M. Levitz(2000). Serum estradiol-binding profiles in postmenopausalwomen undergoing three common estrogen replacement ther-apies:Associations with sex hormone-binding globulin, estra-diol,and estrone levels. Menopause 7: 243–250.

    PubMed  Google Scholar 

  21. E.S. Knochenhauer, L.R. Boots, H.D. Potter, and R. Azziz(1998). Differential binding of estradiol and testosterone toSHBG. Relation to circulating estradiol levels. J.Reprod.Med. 43:665–670.

    PubMed  Google Scholar 

  22. J.M. Cline, G. Soderqvist, E. von Schoultz, L. Skoog, and B. von Schoultz (1996). Effects of hormone replacement therapy onthe mammary gland of surgically postmenopausal macaques. Am.J.Obstet.Gynecol. 174: 93–100.

    PubMed  Google Scholar 

  23. C. Schairer, C. Byrne, P.M. Keyl, L.A. Brinton, S.R. Sturgeon, and R.N. Hoover (1994). Menopausal estrogen and estrogen–progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control 5: 491–500.

    PubMed  Google Scholar 

  24. R.K. Ross, A. Paganini-Hill, P.C. Wan, and M.C. Pike (2000). Effect of hormone replacement therapy on breast cancer risk:Estrogen versus estrogen plus progestin. J.Natl.Cancer Ins. 92: 328–332.

    Google Scholar 

  25. J.M. Grodin, P.K. Siiteri, and P.C. MacDonald (1973). Sourceof estrogen prouction in postmenopausal women. J.Clin.En-docrinol.Metab. 36: 207–214.

    Google Scholar 

  26. M.Lippman, G. Bolan, and K. Huff (1976). The effects of andro-gensand antiandrogens on hormone-responsive human breastcancer in long-term tissue culture. Cancer Res. 36: 4610–4618.

    PubMed  Google Scholar 

  27. P. Hill, L. Garbaczewski, and F. Kasumi (1985). Plasma testos-teroneand breast cancer. Eur.J.Clin.Oncol. 21: 1265–1266.

    Google Scholar 

  28. B.R. Goldin, H. Adlercreutz, S.L. Gorbach, M.N. Woods, J.T. Dwyer, T. Conlon, E. Bohn, and S.N. Gershoff (1986). Therelationship between estrogen levels and diets of CaucasianAmerican and Oriental immigrant women. Am.J.Clin.Nutr. 44: 945–953.

    PubMed  Google Scholar 

  29. T. J.A. Key, J. Chen, D.Y. Wang, M.C. Pike, and J. Boreham(1990). Sex hormones in women in rural China and in Britain. Br.J.Cancer 62: 631–636.

    PubMed  Google Scholar 

  30. H. Shimizu, R.K. Ross, L. Bernstein, M.C. Pike, and B.E. Henderson (1990). Serum estrogen levels in postmenopausalwomen: Comparison of US whites and Japanese in Japan. Br.J.Cancer 62: 451-4.

    PubMed  Google Scholar 

  31. D.K. Wysowski, G.W. Comstock, K.J. Helsing, and H. L. Lau (1987). Sex hormone levels in serum in relation to thedevelopment of breast cancer. Am.J.Epidemiol. 125: 791–799.

    PubMed  Google Scholar 

  32. K.J. Helzlsouer, A.J. Alberg, T.L. Bush, C. Longcope, G.B. Gordon, and G.W. Comstock (1994). A prospective study of endogenous hormones and breast cancer. Cancer Detect.Prev. 18: 79–85.

    PubMed  Google Scholar 

  33. P. Ebeling and V.A. Koivisto (1994). Physiological importanceof dehydroepiandrosterone. Lancet 343: 1479–1481.

    PubMed  Google Scholar 

  34. A.G. Schwartz (1979). Inhibition of spontaneous breast cancerformation in female C3H (Avy/a) mice by long-term treatmentwith dehydroepiandrosterone. Cancer Res. 39: 1129–1132.

    PubMed  Google Scholar 

  35. J. H.H. Thijssen, J. Poortman, and F. Schwarz (1975). Andro-gensin postmenopausal breast cancer: Excretion, productionand interaction with estrogens. J.Steroid Biochem. 6: 729–734.

    PubMed  Google Scholar 

  36. B.K. Vonderhaar (1987). Prolactin transport, function, and re-ceptorsin mammary gland development and differentiation.In M. Neville and C. Daniels (eds.), The Mammary GlandDevelopment, Regulation and Function, Plenum, New York, pp. 383–438.

    Google Scholar 

  37. B.K. Vonderhaar (1999). Prolactin involvement in breastcancer. Endocrine-Rel.Cancer 6: 389–404.

    Google Scholar 

  38. C.W. Welsch and H. Nagasawa (1977). Prolactin and murinemammary tumorigenesis: A review. Cancer Res. 37: 951–963.

    PubMed  Google Scholar 

  39. S.E. Hankinson, W.C. Willett, D.S. Michaud, J.E. Manson, G.A. Colditz, C. Longcope, B. Rosner, and F.E. Speizer (1999). Plasma prolactin levels and subsequent risk of breast cancer inpostmenopausal women. J.Natl.Cancer Inst. 91: 629–634.

    PubMed  Google Scholar 

  40. B.E. Henderson, M.C. Pike, L. Bernstein, and R.K. Ross(1996). Breast cancer. In D. Schottenfeld and J. Fraumeni Jr. (eds.), Cancer Epidemiology and Prevention, 2nd edn., W.B. Saunders, New York, pp. 1022–1039.

    Google Scholar 

  41. B.E. Henderson, M.C. Pike, and J.T. Casagrande (1981). Breastcancer and the oestrogen window hypothesis. Lancet 2: 363–364.

    Google Scholar 

  42. D. Apter and R. Vihko (1983). Early menarche, a risk factor forbreast cancer, indicates early onset of ovulatory cycles. J.Clin.Endocrinol.Metab. 57: 82–86.

    PubMed  Google Scholar 

  43. R. Vihko and D.J. Apter (1984). Endocrine characteristics ofadolescent menstrual cycles: Impact of early menarche. SteroidBiochem. 20: 231–236.

    Google Scholar 

  44. D. Apter, M. Reinila, and R. Vihko (1989). Some endocrinecharacteristics of early menarche, a risk factor for breast cancerare preserved into adulthood. In t.J.Cancer 44: 783–787.

    Google Scholar 

  45. D. Trichopoulos, B. MacMahon, and P. Cole (1972). Themenopause and breast cancer risk. J.Natl.Cancer Inst. 48: 605–613.

    PubMed  Google Scholar 

  46. L.A. Brinton, C. Schairer, R.N. Hoover, and J.F. Fraumeni(1988). Menstrual factors and risk of breast cancer. Cancer Investig. 6: 245–254.

    Google Scholar 

  47. B. MacMahon, P. Cole, M.T. Lin, C.R. Lowe, A.P. Mirra,B. Ravnihar, E.J. Salber, V.G. Valaoras, and S. Yuasa (1970). Age at first birth and cancer of the breast. A summary of aninternational study. Bull.W.H.O. 43: 209–221.

    PubMed  Google Scholar 

  48. J.M. Yuan, M.C. Yu, R.K. Ross, Y.T. Gao, and B.E. Henderson(1988). Risk factors for breast cancer in Chinese women inShanghai. Cancer Res. 48: 1949–1953.

    PubMed  Google Scholar 

  49. P. Bruzzi, E. Negri, C. La Vecchia, A. Decarli, D. Palli, F. Parazzini, and M.R. Del Turco (1988). Short term increasein risk of breast cancer after full term pregnancy. Br.Med.J. 297: 1096–1098.

    Google Scholar 

  50. L. Bernstein, R.H. Depue, R.K. Ross, H.L. Judd, M.C. Pike,and B.E. Henderson (1986). Higher maternal levels of freeestradiol in first compared to second pregnancy: A study ofearly gestational differences. J.Natl.Cancer Inst. 75: 1035–1039.

    Google Scholar 

  51. S.M. Enger, R.K. Ross, H. B. E, and L. Bernstein (1997). Breastfeeding history, pregnancy experience and risk of breast cancer. Br.J.Cancer 76: 118–123.

    PubMed  Google Scholar 

  52. R.H. Depue, L. Bernstein, R.K. Ross, H.L. Judd, M.C. Pike,and B.E. Henderson (1987). Hyperemesis gravidarum in rela-tionto estradiol levels, pregnancy outcome, and other maternal. factors: A sero-epidemiologic study. Am.J.Obstet.Gynecol. 156: 1137–1141.

    PubMed  Google Scholar 

  53. L. Bernstein, M.C. Pike, R.K. Ross, H.L. Judd, J.B. Brown, and B.E. Henderson (1985). Estrogen and sex hormone-bindingglobulin levels in nulliparous and parous women. J.Natl.CancerInst. 74: 741–745.

    Google Scholar 

  54. V.C. Musey, D.C. Collins, P.I. Musey, D. Martino-Saltzman,and J.R. Preedy (1987). Long-term effect of a first preg-nancyon the secretion of prolactin. New Engl.J.Med. 316: 229–234.

    PubMed  Google Scholar 

  55. D.Y. Wang, B. L. de Stavola, R.D. Bulbrook, D.S. Allen, H.G. Kwa, A.A. Verstraeten, J.W. Moore, I.S. Fentiman, J.L. Hayward, and I.H. Gravelle (1988). The permanent effect ofreproductive events on blood prolactin levels and its relationto breast cancer risk: A population study of postmenopausalwomen. Eur.J.Cancer Clin.Oncol. 24: 1225–1231.

    PubMed  Google Scholar 

  56. J.W. Moore, T. J.A. Key, R.D. Bulbrook, G.M. Clark,D.S. Allen, D.Y. Wang, and M.C. Pike (1987). Sex hormonebinding globulin and risk factors for breast cancer in a popu-lationof normal women who had never used exogenous sexhormones. Br.J.Cancer 56: 661–666.

    PubMed  Google Scholar 

  57. P.A. Wingo, K. Newsome, J.S. Marks, E.E. Calle, and S.L. Parker (1997). The risk of breast cancer following sponta-neousand induced abortion. Cancer Causes Control 8: 93–108.

    PubMed  Google Scholar 

  58. P.A. Newcomb, B.E. Storer, M.P. Longnecker, R. Mittendorf,E.R. Greenberg, R.W. Clapp, K.P. Burke, W.C. Willett, and B. MacMahon (1994). Lactation and a reduced risk of pre-menopausalbreast cancer. New Engl.J.Med. 330: 81–86.

    PubMed  Google Scholar 

  59. S.M. Enger, R.K. Ross, A. Paganini-Hill, and L. Bernstein(1998). Breastfeeding experience and breast cancer risk amongpostmenopausal women. Cancer Epidemiol.Biomark.Prev. 7: 365–369.

    Google Scholar 

  60. D.J. Hunter and W.C. Willett (1993). Diet, body size, and breastcancer. Epidemiol.Rev. 15: 110–132.

    PubMed  Google Scholar 

  61. Z. Huang, S.E. Hankinson, G.A. Colditz, M.J. Stampfer,D.J. Hunter, J.E. Manson, C.H. Hennekens, B. Rosner,F.E. Speizer, and W.C. Willett (1997). Dual effects of weightand weight gain on breast cancer risk. J.Am.Med.Assoc. 278: 1407–1411.

    Google Scholar 

  62. P.K. Siiteri and P.C. MacDonald (1973). Role of extraglan-dularestrogen in human endocrinology. In S.R. Geiger, E.B. Astwood, and R.O. Greep (eds.), Handbook of Physiology, American Physiological Society, Washington, DC, pp. 615–629.

    Google Scholar 

  63. T. J.A. Key and M.C. Pike (1988a). The dose–effect relationship between “unopposed” oestrogens and endometrial mitoticrate: Its central role in explaining and predicting endometrial cancer risk. Br.J.Cancer 57: 205–212.

    PubMed  Google Scholar 

  64. G. Ursin, M.P. Longnecker, R.W. Haile, and S. Greenland(1995). A meta-analysis of body mass index and risk of pre-menopausalbreast cancer. Epidemiology 6: 137–141.

    PubMed  Google Scholar 

  65. M.C. Pike (1990). Reducing cancer risk in women throughlifestyle-mediated changes in hormone levels. Cancer Detect.Prev. 14: 595–607.

    PubMed  Google Scholar 

  66. L. Bernstein and B.E. Henderson (1996). Exogenous hormones. In D. Schottenfeld and J. Fraumeni Jr. (eds.), Cancer Epidemiology and Prevention, 2nd edn., W.B. Saunders, New York, pp. 462–488.

    Google Scholar 

  67. L. Bernstein, M.C. Pike, M. Krailo, and B.E. Henderson (1990). Update of the Los Angeles study of oral contraceptives andbreast cancer: 1981 and 1983. In R. Mann (ed.), Oral Contra-ceptivesand Breast Cancer, Parthenon, Park Ridge, NJ, pp. 169–180.

    Google Scholar 

  68. G. Ursin, R.K. Ross, J. Sullivan-Halley, R. Hanisch, B.E. Henderson, and L. Bernstein (1998). Use of oral contracep-tivesand risk of breast cancer in young women. Breast CancerRes.Treat. 50: 175–184.

    Google Scholar 

  69. Collaborative Group on Hormonal Factors in Breast Cancer. (1996a). Breast cancer and hormonal contraceptives. Lancet 347: 1713–1727.

    Google Scholar 

  70. Collaborative Group on Hormonal Factors in Breast Cancer. (1996b). Breast cancer and hormonal contraceptives: Furtherresults. Contraception S 54: 1–106.

    Google Scholar 

  71. J.L. Stanford and D.B. Thomas (1993). Exogenous progestinsand breast cancer. Epidemiol.Rev. 15: 98–107.

    PubMed  Google Scholar 

  72. M.C. Pike, L. Bernstein, and D.V. Spicer (1993). The re-lationshipof exogenous hormones to breast cancer risk. In J. Niederhuber (ed.), Current Therapy in Oncology, Mosby, St. Louis, MO, pp. 292–303.

    Google Scholar 

  73. T.J. Key and M.C. Pike (1988b). The role of oestrogens and pro-gestagensin the epidemiology and prevention of breast cancer. Eur.J.Cancer Clin.Oncol. 13: 29–43.

    Google Scholar 

  74. C. Magnusson, J.A. Baron, N. Correia, R. Bergstrom,H.O. Adami, and I. Persson (1999). Breast-cancer risk follow-inglong-term oestrogen-and oestrogen-progestin-replacementtherapy. In t.J.Cancer 81: 339–344.

    Google Scholar 

  75. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover (2000). Menopausal estrogen and estrogen–progestin replacement therapy and breast cancer risk. J.Am.Med.Assoc. 283: 485–491.

    Google Scholar 

  76. R.E. Frisch, A.V. Gotz-Welbergen, J.W. McArthur,T. Albright, J. Witschi, B. Bullen, J. Birnholz, and R.B. Reed(1981). Delayed menarche and amenorrhea of college athletesin relation to age of onset of training. J.Am.Med.Assoc. 246: 1559–1563.

    Google Scholar 

  77. B. Schwartz, D.C. Cumming, E. Riordan, M. Selye, S.S. Yen,and R.W. Rebar (1981). Exercise-associated amenorrhea: Adistinct entity? Am.J.Obstet.Gynecol. 141: 662–670.

    PubMed  Google Scholar 

  78. M.M. Shangold and H.A. Levine (1982). The effect ofmarathon training upon menstrual function. Am.J.Obstet.Gynecol. 143: 862–869.

    PubMed  Google Scholar 

  79. M.M. Shangold (1985). Exercise and amenorrhea. Sem.Re-prod Endocrinol. 3: 35–43.

    Google Scholar 

  80. E. Dale, D. Gerlach, and A.L. Wilhite (1979). Menstrual dys-functionin distance runners. Obstet.Gynecol. 54: 47–53.

    PubMed  Google Scholar 

  81. K.M. Pirke, U. Schweiger, A. Broocks, R.J. Tuschl, and R.G. Laessle (1990). Luteinizing hormone and follicle stim-ulatinghormone secretion patterns in female athletes withand without menstrual disturbances. Clin.Endocrinol. 33: 345–353.

    Google Scholar 

  82. A. Broocks, K.M. Pirke, U. Schweiger, R.J. Tuschl,R.G. Laessle, T. Strowitzki, E. Horl, T. Horl, W. Haas, and D. Jeschke (1990). Cyclic ovarian function in recreational ath-letes. J.Appl.Physiol. 68: 2083–2086.

    PubMed  Google Scholar 

  83. J.C. Prior, Y.M. Vigna, M.T. Schechter, and A.E. Burgess(1990). Spinal bone loss and ovulatory disturbances. New Engl.J.Med. 323: 1221–1227.

    PubMed  Google Scholar 

  84. L. Bernstein, R.K. Ross, R.A. Lobo, R. Hanisch, M.D. Krailo,and B.E. Henderson (1987). The effects of moderate physicalactivity on menstrual cycle patterns in adolescence: Implica-tionsfor breast cancer prevention. Br.J.Cancer 55: 681–685.

    PubMed  Google Scholar 

  85. J.B. Russell, D. Mitchell, P.I. Musey, and D.C. Collins (1984). The relationship of exercise to anovulatory cycles in female ath-letes:Hormonal and physical characteristics. Obstet.Gynecol. 63: 452–456.

    PubMed  Google Scholar 

  86. C.M. Friedenreich and T.E. Rohan (1995). Areview of physicalactivity and breast cancer. Epidemiology 6: 311–317.

    PubMed  Google Scholar 

  87. A. McTiernan, C. Ulrich, S. Slate, and J. Potter (1998). Physi-calactivity and cancer etiology: Associations and mechanisms. Cancer Causes Control 9: 487–509.

    PubMed  Google Scholar 

  88. L. Bernstein, B.E. Henderson, R. Hanisch, J. Sullivan-Halley,and R.K. Ross (1994). Physical exercise and reduced risk ofbreast cancer in young women. J.Natl.Cancer Inst. 86: 1403–1408.

    PubMed  Google Scholar 

  89. C.L. Carpenter, R.K. Ross, A. Paganini-Hill, and L. Bernstein(1999). Lifetime exercise activity and breast cancer risk amongpost-menopausal women. Br.J.Cancer 80: 1852–1858.

    PubMed  Google Scholar 

  90. G. Jasienska, I. Thune, and P.T. Ellison (2000). Energeticfactors, ovarian steroids and the risk of breast cancer. Eur.J.Cancer Prev. 9: 231–239.

    PubMed  Google Scholar 

  91. J. Russo and I.H. Russo (1987). Development of the human mammary gland. In M. Neville and C. Daniel (eds.), The Mam-maryGland, Plenum, New York, pp. 67–93.

    Google Scholar 

  92. D. Trichopoulos (1990). Hypothesis: Does breast cancer origi-natein utero? Lancet 335: 939–940.

    PubMed  Google Scholar 

  93. R. Anbazhagan and B.A. Gusterson (1994). Prenatal factorsmay influence predisposition to breast cancer. Eur.J.Cancer A 30: 1–3.

    Google Scholar 

  94. E. Petridou, K. Panagiotopoulou, K. Katsouyanni, E. Spanos,and D. Trichopoulos (1990). Tobacco smoking, pregnancy estrogens,and birth weight. Epidemiology 1: 247–250.

    PubMed  Google Scholar 

  95. A. Ekbom, D. Trichopoulos, H.O. Adami, C.C. Hsieh, and S.J. Lan (1992). Evidence of prenatal influences on breastcancer risk. Lancet 340: 1015–1018.

    PubMed  Google Scholar 

  96. K.B. Michels, D. Trichopoulos, J.B. Robins, B.A. Rosner,J.E. Manson, D.J. Hunter, G.A. Colditz, S.E. Hankinson,F.E. Speizer, and W.C. Willett (1996). Birthweight as a riskfactor for breast cancer. Lancet 348: 1542–1546.

    PubMed  Google Scholar 

  97. A. Ekbom, C.C. Hsieh, L. Lipworth, H.O. Adami, and D. Trichopoulos (1997). Intrauterine environment and breastcancer risk in women: Apopulation-based study. J.Natl.CancerInst. 89: 71–76.

    Google Scholar 

  98. A. Shibata and A.Y. Minn (2000). Perinatal sex hormones and risk of breast and prostate cancers in adulthood. Epidemiol.Rev. 22: 239–248.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernstein, L. Epidemiology of Endocrine-Related Risk Factors for Breast Cancer. J Mammary Gland Biol Neoplasia 7, 3–15 (2002). https://doi.org/10.1023/A:1015714305420

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015714305420

Navigation